Second-Line Treatments Second-Line ITP Treatments For people with ITP whose initial steroid-only treatments didn’t work, the ASH guidelines recommend trying a TPO-RA or rituximab as second-line therapies, with more weight given to TPO-RAs. The next options for second-line therapies include a SYK inhibitor (fostamatinib), BTK inhibitor (rilzabrutinib), or mycophenolate mofetil, which the ASH guidelines rank equally because of a lack of more definitive evidence.e60dc2a1-f33c-4a05-9b50-8e3e8e5976299f3127f6-104f-418f-a5a0-4eaec0f65112 The choice of which to go with largely depends on a patient’s preferences and medical history, Dr. Neunert says…

Read the full article at EVERYDAYHEALTH.COM